TAVRA Biosciences supplies cGMP-manufactured stem cell biologics used in orthopedic and regenerative medicine clinical settings.
Our product is manufactured in an FDA-registered, cGMP-compliant, ISO 7-certified cleanroom and available off-the-shelf, ready for immediate use at the point of care. Each lot is released with a third-party verified Certificate of Analysis covering viability, potency, purity, and sterility.
Our work is grounded in a commitment to patient safety and responsible clinical impact. In a category often marked by variability and uneven standards, TAVRA takes an intentionally conservative approach that is anchored in biological rationale, manufacturing rigor, and transparency.
TAVRA supplies stem cell–based biologic products to licensed physicians for localized clinical use. Our focus is on supporting orthopedic, sports medicine, and pain focused clinical practices where regenerative therapies may meaningfully support tissue health, function, and recovery.
